AMREP CORP (AXR) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:AXR • US0321591051

20.6 USD
-0.26 (-1.25%)
Last: Feb 5, 2026, 08:10 PM
Fundamental Rating

7

AXR gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 62 industry peers in the Real Estate Management & Development industry. AXR gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on AXR. With these ratings, AXR could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year AXR was profitable.
  • AXR had a positive operating cash flow in the past year.
  • Each year in the past 5 years AXR has been profitable.
  • AXR had a positive operating cash flow in each of the past 5 years.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • AXR's Return On Assets of 7.49% is amongst the best of the industry. AXR outperforms 96.77% of its industry peers.
  • AXR's Return On Equity of 7.72% is fine compared to the rest of the industry. AXR outperforms 79.03% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.10%, AXR belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AXR is above the industry average of 5.44%.
Industry RankSector Rank
ROA 7.49%
ROE 7.72%
ROIC 7.1%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • AXR has a Profit Margin of 22.86%. This is amongst the best in the industry. AXR outperforms 93.55% of its industry peers.
  • AXR's Profit Margin has declined in the last couple of years.
  • The Operating Margin of AXR (24.45%) is better than 88.71% of its industry peers.
  • AXR's Operating Margin has declined in the last couple of years.
  • The Gross Margin of AXR (41.05%) is better than 70.97% of its industry peers.
  • AXR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.45%
PM (TTM) 22.86%
GM 41.05%
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • AXR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • AXR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AXR has less shares outstanding
  • Compared to 1 year ago, AXR has an improved debt to assets ratio.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 18.74 indicates that AXR is not in any danger for bankruptcy at the moment.
  • AXR has a Altman-Z score of 18.74. This is amongst the best in the industry. AXR outperforms 98.39% of its industry peers.
  • The Debt to FCF ratio of AXR is 0.01, which is an excellent value as it means it would take AXR, only 0.01 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.01, AXR belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
  • AXR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of AXR (0.00) is better than 88.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 18.74
ROIC/WACC0.8
WACC8.93%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 27.73 indicates that AXR has no problem at all paying its short term obligations.
  • The Current ratio of AXR (27.73) is better than 98.39% of its industry peers.
  • AXR has a Quick Ratio of 10.93. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
  • AXR's Quick ratio of 10.93 is amongst the best of the industry. AXR outperforms 96.77% of its industry peers.
Industry RankSector Rank
Current Ratio 27.73
Quick Ratio 10.93
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • AXR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.00%.
  • The Earnings Per Share has been growing slightly by 2.33% on average over the past years.
  • The Revenue for AXR has decreased by -27.32% in the past year. This is quite bad
  • AXR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.46% yearly.
EPS 1Y (TTM)-15%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%-70.4%
Revenue 1Y (TTM)-27.32%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-21.07%

3.2 Future

  • Based on estimates for the next years, AXR will show a small growth in Earnings Per Share. The EPS will grow by 2.71% on average per year.
  • Based on estimates for the next years, AXR will show a quite strong growth in Revenue. The Revenue will grow by 11.91% on average per year.
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.51, which indicates a very decent valuation of AXR.
  • 90.32% of the companies in the same industry are more expensive than AXR, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of AXR to the average of the S&P500 Index (27.67), we can say AXR is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 9.76, the valuation of AXR can be described as very reasonable.
  • 95.16% of the companies in the same industry are more expensive than AXR, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. AXR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.51
Fwd PE 9.76
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AXR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • 77.42% of the companies in the same industry are more expensive than AXR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.51
EV/EBITDA 5.76
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • AXR has a very decent profitability rating, which may justify a higher PE ratio.
  • AXR's earnings are expected to decrease with -2.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AXR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMREP CORP

NYSE:AXR (2/5/2026, 8:10:18 PM)

20.6

-0.26 (-1.25%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)12-12
Earnings (Next)03-05
Inst Owners46.07%
Inst Owner Change-1.72%
Ins Owners45.02%
Ins Owner Change0%
Market Cap109.39M
Revenue(TTM)45.95M
Net Income(TTM)10.50M
Analysts80
Price Target23.46 (13.88%)
Short Float %0.83%
Short Ratio4.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)38.09%
Min EPS beat(2)-50.49%
Max EPS beat(2)126.68%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.16%
Min Revenue beat(2)-37.84%
Max Revenue beat(2)27.52%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-23.33%
PT rev (3m)-23.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.67%
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.28%
Revenue NY rev (1m)-12.55%
Revenue NY rev (3m)-12.55%
Valuation
Industry RankSector Rank
PE 10.51
Fwd PE 9.76
P/S 2.38
P/FCF 24.51
P/OCF 21.85
P/B 0.8
P/tB 0.8
EV/EBITDA 5.76
EPS(TTM)1.96
EY9.51%
EPS(NY)2.11
Fwd EY10.25%
FCF(TTM)0.84
FCFY4.08%
OCF(TTM)0.94
OCFY4.58%
SpS8.65
BVpS25.62
TBVpS25.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number33.61
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 7.72%
ROCE 8.26%
ROIC 7.1%
ROICexc 10.57%
ROICexgc 10.61%
OM 24.45%
PM (TTM) 22.86%
GM 41.05%
FCFM 9.71%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
ROICexc(3y)10.52%
ROICexc(5y)13.87%
ROICexgc(3y)10.56%
ROICexgc(5y)13.9%
ROCE(3y)9.27%
ROCE(5y)12.5%
ROICexgc growth 3Y-24.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.15%
ROICexc growth 5YN/A
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 223.46%
Cap/Sales 1.18%
Interest Coverage 250
Cash Conversion 43.61%
Profit Quality 42.5%
Current Ratio 27.73
Quick Ratio 10.93
Altman-Z 18.74
F-Score5
WACC8.93%
ROIC/WACC0.8
Cap/Depr(3y)283.02%
Cap/Depr(5y)282.35%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.91%
Profit Quality(3y)86%
Profit Quality(5y)103.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-15%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%-70.4%
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue 1Y (TTM)-27.32%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-21.07%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%
EBIT growth 1Y-11.28%
EBIT growth 3Y-17.16%
EBIT growth 5YN/A
EBIT Next Year19.88%
EBIT Next 3Y1.05%
EBIT Next 5Y6.19%
FCF growth 1Y-50.66%
FCF growth 3Y-12.03%
FCF growth 5Y66.27%
OCF growth 1Y-45.53%
OCF growth 3Y-12.86%
OCF growth 5Y67.79%

AMREP CORP / AXR FAQ

What is the fundamental rating for AXR stock?

ChartMill assigns a fundamental rating of 7 / 10 to AXR.


What is the valuation status of AMREP CORP (AXR) stock?

ChartMill assigns a valuation rating of 7 / 10 to AMREP CORP (AXR). This can be considered as Undervalued.


How profitable is AMREP CORP (AXR) stock?

AMREP CORP (AXR) has a profitability rating of 7 / 10.


How financially healthy is AMREP CORP?

The financial health rating of AMREP CORP (AXR) is 9 / 10.